{"transactions":[{"id":1085934,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2025-07-18T00:48:47.000Z","date":"2025-07-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9556,"price":3.85,"value":36790.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,335 shares and 3,888 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2024 and June 30, 2025, respectively."}],"balance_after":460791,"source":{"system":"sec-edgar","filing":"0000950170-25-096742","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017025096742/ownership.xml","form_type":"4"}},{"id":1134228,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2025-05-27T23:26:54.000Z","date":"2025-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":15630,"price":4.12,"value":64395.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units."}],"balance_after":465124,"source":{"system":"sec-edgar","filing":"0000950170-25-077997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017025077997/ownership.xml","form_type":"4"}},{"id":1499617,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2024-05-30T01:00:03.000Z","date":"2024-05-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":16151,"price":4.78,"value":77201.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units."}],"balance_after":351754,"source":{"system":"sec-edgar","filing":"0000950170-24-066205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017024066205/ownership.xml","form_type":"4"}},{"id":1512532,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Performance Restricted Stock Unit","published_at":"2024-05-18T01:00:19.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":158000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance-based restricted stock unit will vest on July 15, 2027.  The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2024 until June 30, 2027 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The performance-based restricted stock unit will vest on July 15, 2027.  The number of shares delivered on the vesting date, as a percentage of the target specified in Box 5 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from July 1, 2024 until June 30, 2027 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same three-year period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above."}],"balance_after":158000,"derivative":{"underlying":"Common Stock, $.01 Par Value","underlying_shares":158000},"source":{"system":"sec-edgar","filing":"0000950170-24-062067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017024062067/ownership.xml","form_type":"4"}},{"id":1512531,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-05-18T01:00:19.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":129000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquired pursuant to a Restricted Stock Unit Award: 25% vests on July 15, 2025 and each yearly anniversary thereof until fully vested."}],"balance_after":496905,"source":{"system":"sec-edgar","filing":"0000950170-24-062067","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000095017024062067/ownership.xml","form_type":"4"}},{"id":1659777,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2024-02-05T11:00:23.000Z","date":"2024-02-04","kind":"grant","planned":false,"acquired":true,"shares":152905,"price":3.27,"value":499999.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on February 4, 2024."}],"balance_after":367905,"source":{"system":"sec-edgar","filing":"0001209191-24-002743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919124002743/doc4.xml","form_type":"4"}},{"id":1659776,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2024-02-05T11:00:23.000Z","date":"2023-12-31","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":3.09,"value":15450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Includes 5000 shares of common stock purchased under the Company's Employee Stock Purchase Plan on December 31, 2023 in an exempt transaction."}],"balance_after":215000,"source":{"system":"sec-edgar","filing":"0001209191-24-002743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919124002743/doc4.xml","form_type":"4"}},{"id":1877195,"issuer":{"id":4792,"kind":"organization","name":"MANNKIND CORP","symbol":"MNKD"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-05-27T01:00:30.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of MNKD common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"4-year vesting schedule with 1/4th of shares vesting on the first anniversary of the vesting determination date and on each anniversary thereafter until fully vested on the fourth anniversary of the vesting determination date.  The vesting determination date for this grant is May 24, 2023."}],"balance_after":210000,"source":{"system":"sec-edgar","filing":"0001209191-23-032719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899460/000120919123032719/doc4.xml","form_type":"4"}},{"id":2807102,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Common Stock","published_at":"2021-03-05T18:33:19.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":11125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units, each representing a contingent right to one share of common stock which, subject to continued service, vests in installments of 40%, 20%, and 40% at 6 months, 12 months, and 18 months, respectively, after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Holdings were adjusted to reflect the issuer's 1-for-6 reverse stock split effected on December 31, 2020."}],"balance_after":18527,"source":{"system":"sec-edgar","filing":"0001209191-21-018358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919121018358/doc4.xml","form_type":"4"}},{"id":3026328,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Common Stock","published_at":"2020-09-21T08:26:20.000Z","date":"2020-09-17","kind":"grant","acquired":true,"shares":3015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of the issuer's Common Stock that will be issued to the reporting person based on the vesting of restricted stock units that were previously awarded to the reporting person. The vesting of the shares under the restricted stock units was based on the issuer's achievement of a performance milestone that was specified at the time the restricted stock units were awarded."}],"balance_after":44410,"source":{"system":"sec-edgar","filing":"0001209191-20-051237","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919120051237/doc4.xml","form_type":"4"}},{"id":3375163,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-12T07:58:30.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options issued under the issuer's 2015 Omnibus Incentive Compensation Plan.  The shares subject to the options vest in equal quarterly installments over two years beginning on November 7, 2019 with the first quarterly installment vesting on February 7, 2020."}],"balance_after":80000,"derivative":{"exercise_price":2.41,"expiration_date":"2029-11-07","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-19-055900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919119055900/doc4.xml","form_type":"4"}},{"id":3600143,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-12T16:11:28.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to this option will vest in full on March 8, 2020."}],"balance_after":15000,"derivative":{"exercise_price":13.51,"expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-018786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919119018786/doc4.xml","form_type":"4"}},{"id":3600142,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-12T16:11:28.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":15075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan.  The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2019 with the first quarterly installment vesting on April 1, 2019."}],"balance_after":15075,"derivative":{"exercise_price":13.51,"expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":15075},"source":{"system":"sec-edgar","filing":"0001209191-19-018786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919119018786/doc4.xml","form_type":"4"}},{"id":3600141,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO and Head of R&D"}}],"security":"Common Stock","published_at":"2019-03-12T16:11:28.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":9045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares will vest 25% every year for four years with vest dates of December 1, 2019, December 1, 2020, December 1, 2021 and December 1, 2022."}],"balance_after":41395,"source":{"system":"sec-edgar","filing":"0001209191-19-018786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919119018786/doc4.xml","form_type":"4"}},{"id":3718330,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-27T08:07:34.000Z","date":"2018-12-22","kind":"grant","acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of the issuer's Common Stock that will be issued to the reporting person based on the vesting of restricted stock units that were previously awarded to the reporting person. The vesting of the shares under the restricted stock units was based on the issuer's achievement of a performance milestone that was specified at the time the restricted stock units were awarded."}],"balance_after":32350,"source":{"system":"sec-edgar","filing":"0001209191-18-064139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118064139/doc4.xml","form_type":"4"}},{"id":3818768,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-12T16:07:03.000Z","date":"2018-09-10","kind":"grant","acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the number of shares of the issuer's Common Stock that will be issued to the reporting person based on the vesting of restricted stock units that were previously awarded to the reporting person. The vesting of the shares under the restricted stock units was based on the issuer's achievement of a performance milestone that was specified at the time the restricted stock units were awarded."}],"balance_after":30250,"source":{"system":"sec-edgar","filing":"0001209191-18-050624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118050624/doc4.xml","form_type":"4"}},{"id":3853873,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-03T07:46:36.000Z","date":"2018-08-01","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest over two years from the May 1, 2017 grant date, with the first 25% having vested at the end of six months\nafter the grant date and the remaining 75% vesting in equal quarterly installments over the remainder of such two year period."}],"balance_after":18750,"derivative":{"exercise_price":16.5,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001209191-18-045130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118045130/doc4.xml","form_type":"4"}},{"id":3853872,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-03T07:46:36.000Z","date":"2018-08-01","kind":"sale","acquired":false,"shares":6250,"price":24.6915,"value":154321.875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $24.40 to $25.30 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of  sold at each price within the range."}],"balance_after":28150,"source":{"system":"sec-edgar","filing":"0001209191-18-045130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118045130/doc4.xml","form_type":"4"}},{"id":3853871,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-03T07:46:36.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":6250,"price":16.5,"value":103125.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan."}],"balance_after":34400,"source":{"system":"sec-edgar","filing":"0001209191-18-045130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118045130/doc4.xml","form_type":"4"}},{"id":3876509,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-03T17:33:21.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":2859,"price":29.8748,"value":85412.0532,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sales pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $29.65 to $30.10 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":28150,"source":{"system":"sec-edgar","filing":"0001209191-18-041247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118041247/doc4.xml","form_type":"4"}},{"id":3876508,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-03T17:33:21.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":2141,"price":29.2566,"value":62638.3806,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sales pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.65 to $29.60 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":31009,"source":{"system":"sec-edgar","filing":"0001209191-18-041247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118041247/doc4.xml","form_type":"4"}},{"id":3922719,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-22T16:33:34.000Z","date":"2018-05-18","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest over two years from the May 1, 2017 grant date, with the first 25% having vested at the end of six months after the grant date and the remaining 75% vesting in equal quarterly installments over the remainder of such two year period."}],"balance_after":25000,"derivative":{"exercise_price":16.5,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-032314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118032314/doc4.xml","form_type":"4"}},{"id":3922718,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-22T16:33:34.000Z","date":"2018-05-18","kind":"sale","acquired":false,"shares":25000,"price":23.6635,"value":591587.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $23.45 to $24.15 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":33150,"source":{"system":"sec-edgar","filing":"0001209191-18-032314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118032314/doc4.xml","form_type":"4"}},{"id":3922717,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-05-22T16:33:34.000Z","date":"2018-05-18","kind":"exercise","acquired":true,"shares":25000,"price":16.5,"value":412500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Exercise and sales pursuant to a 10b5-1 plan."}],"balance_after":58150,"source":{"system":"sec-edgar","filing":"0001209191-18-032314","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919118032314/doc4.xml","form_type":"4"}},{"id":4143001,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-05T07:36:13.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":11050,"price":20.5333,"value":226892.965,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sales pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.05 to $20.90 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":33150,"source":{"system":"sec-edgar","filing":"0001209191-17-063695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117063695/doc4.xml","form_type":"4"}},{"id":4335913,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-03T16:17:27.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest over two years from the May 1, 2017 grant date, with the first 25% to vest at the end of six months after the grant date and the remaining 75% to vest in equal quarterly installments over the remainder of such two year period."}],"balance_after":50000,"derivative":{"exercise_price":16.5,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-029651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117029651/doc4.xml","form_type":"4"}},{"id":4405868,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-03T16:03:26.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2017 with the first quarterly installment vesting on April 1, 2017."}],"balance_after":10500,"derivative":{"exercise_price":27.475,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-17-017398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117017398/doc4.xml","form_type":"4"}},{"id":4405867,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-03T16:03:26.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted shares issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares will vest 25% every year for four years with vest dates of December 1, 2017, December 1, 2018, December 1, 2019 and December 1, 2020."}],"balance_after":44200,"source":{"system":"sec-edgar","filing":"0001209191-17-017398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919117017398/doc4.xml","form_type":"4"}},{"id":4533943,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":77440,"kind":"person","name":"BLANK BURKHARD","position":1,"cik":"0001073409","reported_name":"BLANK BURKHARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-05T17:06:14.000Z","date":"2016-12-01","kind":"sale","acquired":false,"shares":10000,"price":20.7442,"value":207442.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sales pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.30 to $21.25 per share.  The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-16-153400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919116153400/doc4.xml","form_type":"4"}}]}